採用

[Quality] Safety Management Specialist-GVP [Heart Recovery]
Chuo-ku, Tokyo, Japan
·
On-site
·
Full-time
·
1mo ago
必須スキル
Excel
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com
Job Function:
Quality
Job Sub Function:
Customer/Commercial Quality
Job Category:
Professional
All Job Posting Locations:
Chuo-ku, Tokyo, Japan
Job Description:
Job Responsibilities:
GVP staff is responsible for GVP activities including complaint handling and adverse event reporting to competent authority in Japan. He/she works at Tokyo Office closely and reports to Safety/GVP manager.
Principle Duties and Responsibilities:
- Creating and submitting adverse event reports to PMDA.
- Handling and assessing complaints and safety issues
- Maintaining and updating Japanese IFUs and user manuals
- Controlling documents, procedures, and records related to GVP and post-market activities.
- Collaborating with product assurance and post-market engineering teams in the US headquarters.
- Obtaining complaint investigation results from the US headquarters and creating customer letters.
Job Qualifications:
-
Minimum 2 years of GVP and/or post-market engineering experience in the medical industries
-
Good knowledge about GVP Ordinances and adverse event reporting
-
Basic knowledge of Japan PMDA Act and QMS Ordinance
-
English reading and writing skills (e.g., e-mail communication, translation of complaint information)
-
Basic PC skills (Microsoft Excel, Word, PowerPoint, Access, Outlook)
-
Preferred to have knowledge of cardiovascular related products
-
Business level English communication skill
Required Skills:
Preferred Skills:
Business Behavior, Compliance Management, Continuous Improvement, Data Analysis, Data Compilation, Detail-Oriented, Execution Focus, Goal Attainment, Internal Controls, Issue Escalation, Process Oriented, Quality Control (QC), Quality Management Systems (QMS), Quality Standards, Regulatory Environment, Report Writing
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Tech/Systems Support Analyst
IQVIA · Tokyo, Japan

Customer Experience Agent (Japanese Speaking)
Whatnot · Tokyo, Japan

Sales Operations Analyst
SailPoint · Remote (Japan)

Country Communications Specialist
ABB · Tokyo, Tokyo, Japan

Global Investment Banking - FIG Coverage - Analyst
JPMorgan Chase · Tokyo-To, Japan, JP
Johnson & Johnsonについて

Johnson & Johnson
PublicJohnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
10,001+
従業員数
New Brunswick
本社所在地
$400B
企業価値
レビュー
4.0
10件のレビュー
ワークライフバランス
3.8
報酬
4.2
企業文化
4.1
キャリア
3.5
経営陣
4.3
75%
友人に勧める
良い点
Supportive and approachable management
Excellent benefits and compensation
Flexible work arrangements and work-life balance
改善点
High-pressure and demanding work environment
Slow bureaucratic processes
Heavy workload and high expectations
給与レンジ
2,250件のデータ
Mid/L4
Senior/L5
Director
Mid/L4 · Manager
338件のレポート
$155,591
年収総額
基本給
$137,488
ストック
-
ボーナス
$18,103
$106,549
$229,934
面接体験
7件の面接
難易度
3.0
/ 5
期間
14-28週間
面接プロセス
1
Application Review
2
HR Screen
3
Pre-recorded/Video Interview
4
Technical/Panel Interview
5
Final Interview
6
Offer
よくある質問
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
ニュース&話題
Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports - Reuters
Reuters
News
·
4d ago
Johnson & Johnson to launch on TrumpRx with 4 of its prescription drugs - CBS News
CBS News
News
·
4d ago
Phase III data show J&J’s Imaavy provides long-term disease control for people with gMG - The Pharma Letter
The Pharma Letter
News
·
4d ago
Cramer's Stop Trading: Johnson & Johnson - CNBC
CNBC
News
·
4d ago